References analysis of the Wikipedia article "Cannabinoid receptor" in the English version

doi.org

Howlett AC (August 2002). "The cannabinoid receptors". Prostaglandins & Other Lipid Mediators. 68–69: 619–31. doi:10.1016/S0090-6980(02)00060-6. PMID 12432948.

Mackie K (May 2008). "Cannabinoid receptors: where they are and what they do". Journal of Neuroendocrinology. 20 (Suppl 1): 10–4. doi:10.1111/j.1365-2826.2008.01671.x. PMID 18426493. S2CID 20161611.

Graham ES, Ashton JC, Glass M (January 2009). "Cannabinoid Receptors: A brief history and what not". Frontiers in Bioscience. 14 (14): 944–57. doi:10.2741/3288. PMID 19273110.

Aizpurua-Olaizola O, Elezgarai I, Rico-Barrio I, Zarandona I, Etxebarria N, Usobiaga A (January 2017). "Targeting the endocannabinoid system: future therapeutic strategies". Drug Discovery Today. 22 (1): 105–110. doi:10.1016/j.drudis.2016.08.005. PMID 27554802. S2CID 3460960. Archived from the original on 2023-01-27. Retrieved 2022-10-19.

Galiègue S, Mary S, Marchand J, Dussossoy D, Carrière D, Carayon P, et al. (August 1995). "Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations". European Journal of Biochemistry. 232 (1): 54–61. doi:10.1111/j.1432-1033.1995.tb20780.x. PMID 7556170.

Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (August 1990). "Structure of a cannabinoid receptor and functional expression of the cloned cDNA". Nature. 346 (6284): 561–4. Bibcode:1990Natur.346..561M. doi:10.1038/346561a0. PMID 2165569. S2CID 4356509.

Gérard CM, Mollereau C, Vassart G, Parmentier M (October 1991). "Molecular cloning of a human cannabinoid receptor which is also expressed in testis". The Biochemical Journal. 279 (Pt 1): 129–34. doi:10.1042/bj2790129. PMC 1151556. PMID 1718258.

Pacher P, Mechoulam R (April 2011). "Is lipid signaling through cannabinoid 2 receptors part of a protective system?". Progress in Lipid Research. 50 (2): 193–211. doi:10.1016/j.plipres.2011.01.001. PMC 3062638. PMID 21295074.

Jordan CJ, Xi ZX (March 2019). "Progress in brain cannabinoid CB2 receptor research: From genes to behavior". Neuroscience and Biobehavioral Reviews. 98: 208–220. doi:10.1016/j.neubiorev.2018.12.026. PMC 6401261. PMID 30611802.

Latek D, Kolinski M, Ghoshdastider U, Debinski A, Bombolewski R, Plazinska A, et al. (September 2011). "Modeling of ligand binding to G protein coupled receptors: cannabinoid CB1, CB2 and adrenergic β 2 AR". Journal of Molecular Modeling. 17 (9): 2353–66. doi:10.1007/s00894-011-0986-7. PMID 21365223. S2CID 28365397.

Munro S, Thomas KL, Abu-Shaar M (September 1993). "Molecular characterization of a peripheral receptor for cannabinoids". Nature. 365 (6441): 61–5. Bibcode:1993Natur.365...61M. doi:10.1038/365061a0. PMID 7689702. S2CID 4349125.

Kyrou I, Valsamakis G, Tsigos C (November 2006). "The endocannabinoid system as a target for the treatment of visceral obesity and metabolic syndrome". Annals of the New York Academy of Sciences. 1083 (1): 270–305. Bibcode:2006NYASA1083..270K. doi:10.1196/annals.1367.024. PMID 17148745. S2CID 23486551.

Elphick MR (December 2012). "The evolution and comparative neurobiology of endocannabinoid signalling". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 367 (1607): 3201–15. doi:10.1098/rstb.2011.0394. PMC 3481536. PMID 23108540.

Elphick MR, Egertová M (March 2001). "The neurobiology and evolution of cannabinoid signalling". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences (Review). 356 (1407): 381–408. doi:10.1098/rstb.2000.0787. PMC 1088434. PMID 11316486.

Pertwee RG (January 2006). "Cannabinoid pharmacology: the first 66 years". British Journal of Pharmacology (Review). 147 (Suppl 1): S163–71. doi:10.1038/sj.bjp.0706406. PMC 1760722. PMID 16402100.

Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, et al. (June 2002). "International Union of Pharmacology. XXVII. Classification of cannabinoid receptors". Pharmacological Reviews (Review). 54 (2): 161–202. doi:10.1124/pr.54.2.161. PMID 12037135. S2CID 8259002.

Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, et al. (December 1992). "Isolation and structure of a brain constituent that binds to the cannabinoid receptor". Science. 258 (5090): 1946–9. Bibcode:1992Sci...258.1946D. doi:10.1126/science.1470919. PMID 1470919.

Hanus LO (August 2007). "Discovery and isolation of anandamide and other endocannabinoids". Chemistry & Biodiversity. 4 (8): 1828–41. doi:10.1002/cbdv.200790154. PMID 17712821. S2CID 745528.

Osei-Hyiaman D, DePetrillo M, Pacher P, Liu J, Radaeva S, Bátkai S, et al. (May 2005). "Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity". The Journal of Clinical Investigation. 115 (5): 1298–305. doi:10.1172/JCI23057. PMC 1087161. PMID 15864349.

Onaivi J (2019). "Endocannabinoid System Components: Overview and Tissue Distribution". In Bukiya A (ed.). Recent Advances in Cannabinoid Physiology and Pathology. Advances in Experimental Medicine and Biology. Vol. 1162. Cham.: Springer. pp. 1–12. doi:10.1007/978-3-030-21737-2_1. ISBN 978-3-030-21736-5. PMID 31332731. S2CID 198172390. Archived from the original on 20 April 2023. Retrieved 19 October 2021.

Járai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, et al. (November 1999). "Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors". Proceedings of the National Academy of Sciences of the United States of America. 96 (24): 14136–41. Bibcode:1999PNAS...9614136J. doi:10.1073/pnas.96.24.14136. PMC 24203. PMID 10570211.

McHugh D, Tanner C, Mechoulam R, Pertwee RG, Ross RA (February 2008). "Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2". Molecular Pharmacology. 73 (2): 441–50. doi:10.1124/mol.107.041863. PMID 17965195. S2CID 15182303.

McHugh D, Hu SS, Rimmerman N, Juknat A, Vogel Z, Walker JM, Bradshaw HB (March 2010). "N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor". BMC Neuroscience. 11: 44. doi:10.1186/1471-2202-11-44. PMC 2865488. PMID 20346144.

Ryberg E, Larsson N, Sjögren S, Hjorth S, Hermansson NO, Leonova J, et al. (December 2007). "The orphan receptor GPR55 is a novel cannabinoid receptor". British Journal of Pharmacology. 152 (7): 1092–101. doi:10.1038/sj.bjp.0707460. PMC 2095107. PMID 17876302.

Johns DG, Behm DJ, Walker DJ, Ao Z, Shapland EM, Daniels DA, et al. (November 2007). "The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects". British Journal of Pharmacology. 152 (5): 825–31. doi:10.1038/sj.bjp.0707419. PMC 2190033. PMID 17704827.

Overton HA, Babbs AJ, Doel SM, Fyfe MC, Gardner LS, Griffin G, et al. (March 2006). "Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents". Cell Metabolism. 3 (3): 167–75. doi:10.1016/j.cmet.2006.02.004. PMID 16517404.

de Fonseca FR, Schneider M (June 2008). "The endogenous cannabinoid system and drug addiction: 20 years after the discovery of the CB1 receptor" (PDF). Addiction Biology. 13 (2): 143–6. doi:10.1111/j.1369-1600.2008.00116.x. PMID 18482429. S2CID 205400322. Archived from the original (PDF) on 2011-07-18.

Brown AJ (November 2007). "Novel cannabinoid receptors". British Journal of Pharmacology. 152 (5): 567–75. doi:10.1038/sj.bjp.0707481. PMC 2190013. PMID 17906678.

O'Sullivan SE (June 2016). "An update on PPAR activation by cannabinoids". British Journal of Pharmacology. 173 (12): 1899–910. doi:10.1111/bph.13497. PMC 4882496. PMID 27077495.

Demuth DG, Molleman A (January 2006). "Cannabinoid signalling". Life Sciences. 78 (6): 549–63. doi:10.1016/j.lfs.2005.05.055. PMID 16109430.

Saroz Y, Kho DT, Glass M, Graham ES, Grimsey NL (October 2019). "Cannabinoid Receptor 2 (CB2) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary Leukocytes". ACS Pharmacology & Translational Science. 2 (6): 414–428. doi:10.1021/acsptsci.9b00049. PMC 7088898. PMID 32259074.

Richardson KA, Hester AK, McLemore GL (2016). "Prenatal cannabis exposure - The "first hit" to the endocannabinoid system". review. Neurotoxicology and Teratology. 58: 5–14. doi:10.1016/j.ntt.2016.08.003. PMID 27567698. S2CID 5656802.

Calvigioni D, Hurd YL, Harkany T, Keimpema E (October 2014). "Neuronal substrates and functional consequences of prenatal cannabis exposure". review. European Child & Adolescent Psychiatry. 23 (10): 931–41. doi:10.1007/s00787-014-0550-y. PMC 4459494. PMID 24793873.

Badowski ME (September 2017). "A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics". Cancer Chemotherapy and Pharmacology. 80 (3): 441–449. doi:10.1007/s00280-017-3387-5. PMC 5573753. PMID 28780725.

Korte G, Dreiseitel A, Schreier P, Oehme A, Locher S, Geiger S, et al. (January 2010). "Tea catechins' affinity for human cannabinoid receptors". Phytomedicine. 17 (1): 19–22. doi:10.1016/j.phymed.2009.10.001. PMID 19897346.

Ligresti A, Villano R, Allarà M, Ujváry I, Di Marzo V (August 2012). "Kavalactones and the endocannabinoid system: the plant-derived yangonin is a novel CB₁ receptor ligand". Pharmacological Research. 66 (2): 163–9. doi:10.1016/j.phrs.2012.04.003. PMID 22525682.

Frost JM, Dart MJ, Tietje KR, Garrison TR, Grayson GK, Daza AV, et al. (January 2010). "Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity". Journal of Medicinal Chemistry. 53 (1): 295–315. doi:10.1021/jm901214q. PMID 19921781.

Aung MM, Griffin G, Huffman JW, Wu M, Keel C, Yang B, et al. (August 2000). "Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding". Drug and Alcohol Dependence. 60 (2): 133–40. doi:10.1016/S0376-8716(99)00152-0. PMID 10940540.

figshare.com

harvard.edu

ui.adsabs.harvard.edu

nih.gov

pubmed.ncbi.nlm.nih.gov

Howlett AC (August 2002). "The cannabinoid receptors". Prostaglandins & Other Lipid Mediators. 68–69: 619–31. doi:10.1016/S0090-6980(02)00060-6. PMID 12432948.

Graham ES, Ashton JC, Glass M (January 2009). "Cannabinoid Receptors: A brief history and what not". Frontiers in Bioscience. 14 (14): 944–57. doi:10.2741/3288. PMID 19273110.

Hanus LO (August 2007). "Discovery and isolation of anandamide and other endocannabinoids". Chemistry & Biodiversity. 4 (8): 1828–41. doi:10.1002/cbdv.200790154. PMID 17712821. S2CID 745528.

Brown AJ (November 2007). "Novel cannabinoid receptors". British Journal of Pharmacology. 152 (5): 567–75. doi:10.1038/sj.bjp.0707481. PMC 2190013. PMID 17906678.

O'Sullivan SE (June 2016). "An update on PPAR activation by cannabinoids". British Journal of Pharmacology. 173 (12): 1899–910. doi:10.1111/bph.13497. PMC 4882496. PMID 27077495.

Demuth DG, Molleman A (January 2006). "Cannabinoid signalling". Life Sciences. 78 (6): 549–63. doi:10.1016/j.lfs.2005.05.055. PMID 16109430.

ncbi.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org

Hanus LO (August 2007). "Discovery and isolation of anandamide and other endocannabinoids". Chemistry & Biodiversity. 4 (8): 1828–41. doi:10.1002/cbdv.200790154. PMID 17712821. S2CID 745528.

Cannabinoid receptor (English Wikipedia)

doi.org

espacenet.com

v3.espacenet.com

figshare.com

harvard.edu

ui.adsabs.harvard.edu

medicines.org.uk

nih.gov

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org

unc.edu

pdsp.med.unc.edu

web.archive.org

zi-mannheim.de